64 related articles for article (PubMed ID: 17653231)
1. Vitamin D receptor: a highly versatile nuclear receptor.
Wu-Wong JR
Kidney Int; 2007 Aug; 72(3):237-9. PubMed ID: 17653231
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D activates type A natriuretic peptide receptor gene transcription in inner medullary collecting duct cells.
Chen S; Olsen K; Grigsby C; Gardner DG
Kidney Int; 2007 Aug; 72(3):300-6. PubMed ID: 17440494
[TBL] [Abstract][Full Text] [Related]
3. Role of the vitamin D receptor in FGF23 action on phosphate metabolism.
Inoue Y; Segawa H; Kaneko I; Yamanaka S; Kusano K; Kawakami E; Furutani J; Ito M; Kuwahata M; Saito H; Fukushima N; Kato S; Kanayama HO; Miyamoto K
Biochem J; 2005 Aug; 390(Pt 1):325-31. PubMed ID: 15885032
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease in chronic kidney failure: the role of VDR activators.
Wu-Wong JR; Tian J; Nakane M; Ma J; Fey TA; Kroeger P; Fryer RM; Reinhart GA
Curr Opin Investig Drugs; 2006 Mar; 7(3):206-13. PubMed ID: 16555680
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation.
Andress DL
Kidney Int; 2006 Jan; 69(1):33-43. PubMed ID: 16374421
[TBL] [Abstract][Full Text] [Related]
6. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
[TBL] [Abstract][Full Text] [Related]
7. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
8. 1,25 dihydroxyvitamin d amplifies type a natriuretic peptide receptor expression and activity in target cells.
Chen S; Ni XP; Humphreys MH; Gardner DG
J Am Soc Nephrol; 2005 Feb; 16(2):329-39. PubMed ID: 15590756
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine impairs the guanylyl cyclase activity of the natriuretic peptide receptor in the glomerulus.
Kook H; Kim SW; Kang SY; Kim SZ; Kim JH; Choi KC; Lee J; Cho KW; Baik YH
Pharmacol Res; 2000 Nov; 42(5):435-41. PubMed ID: 11023705
[TBL] [Abstract][Full Text] [Related]
10. Novel analog of atrial natriuretic peptide selective for receptor-A produces increased diuresis and natriuresis in rats.
Jin H; Li B; Cunningham B; Tom J; Yang R; Sehl P; Thomas GR; Ko A; Oare D; Lowe DG
J Clin Invest; 1996 Aug; 98(4):969-76. PubMed ID: 8770869
[TBL] [Abstract][Full Text] [Related]
11. Endothelin inhibits NPR-A and stimulates eNOS gene expression in rat IMCD cells.
Ye Q; Chen S; Gardner DG
Hypertension; 2003 Mar; 41(3 Pt 2):675-81. PubMed ID: 12623978
[TBL] [Abstract][Full Text] [Related]
12. Role of cyclic GMP and calcineurin in homologous and heterologous desensitization of natriuretic peptide receptor-A.
Fortin Y; De Léan A
Can J Physiol Pharmacol; 2006 May; 84(5):539-46. PubMed ID: 16902599
[TBL] [Abstract][Full Text] [Related]
13. Mesangial cells from diabetic NOD mice constitutively express increased density of atrial natriuretic peptide C receptors.
Ardaillou N; Placier S; Striker L; Striker G; Ardaillou R
Kidney Int; 1999 Apr; 55(4):1293-302. PubMed ID: 10200993
[TBL] [Abstract][Full Text] [Related]
14. Natriuretic peptide guanylyl cyclase receptors in the kidney of the Japanese eel, Anguilla japonica.
Healy JM; Donald JA; Hyodo S; Toop T; Takei Y
Cell Tissue Res; 2005 May; 320(2):311-22. PubMed ID: 15789218
[TBL] [Abstract][Full Text] [Related]
15. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
16. The potential for vitamin D receptor activation in cardiovascular research.
Wu-Wong JR
Expert Opin Investig Drugs; 2007 Apr; 16(4):407-11. PubMed ID: 17371189
[TBL] [Abstract][Full Text] [Related]
17. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B.
Thibault G; Grove KL; Deschepper CF
Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004
[TBL] [Abstract][Full Text] [Related]
18. Signaling and distribution of NPR-Bi, the human splice form of the natriuretic peptide receptor type B.
Hirsch JR; Skutta N; Schlatter E
Am J Physiol Renal Physiol; 2003 Aug; 285(2):F370-4. PubMed ID: 12709393
[TBL] [Abstract][Full Text] [Related]
19. Importance of vitamin D receptor activation in clinical practice.
Cozzolino M; Fallabrino G; Pasho S; Olivi L; Ciceri P; Volpi E; Gallieni M; Brancaccio D
Contrib Nephrol; 2009; 163():213-218. PubMed ID: 19494616
[TBL] [Abstract][Full Text] [Related]
20. [Cardioprotective effect of vitamin D in nondialyzed patients with stage 3-5 CKD].
Cozzolino M; Mehmeti F; Bonelli F; Ronga C; Musetti C; Missaglia E; Stucchi A; Colombo F; Tavecchia M; Cuoccio P; Brenna I; Volpi E; Ciceri P; Cusi D
G Ital Nefrol; 2010; 27 Suppl 52():S27-31. PubMed ID: 21132659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]